Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001104659-20-070350
Filing Date
2020-06-05
Accepted
2020-06-05 16:34:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B2 tm2021463-2_424b2.htm 424B2 504884
2 GRAPHIC lg_menlotherapeutics-4clr.jpg GRAPHIC 126596
  Complete submission text file 0001104659-20-070350.txt   680521
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-229482 | Film No.: 20946784
SIC: 2834 Pharmaceutical Preparations